In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility

被引:27
|
作者
Cota, Jason [1 ]
Carden, Michael [1 ]
Graybill, John R. [1 ]
Najvar, Laura K. [1 ]
Burgess, David S. [1 ]
Wiederhold, Nathan P. [1 ]
机构
[1] UTHSCSA, Austin Coll Pharm, Clin Pharm, San Antonio, TX 78229 USA
关键词
D O I
10.1128/AAC.00538-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of anidulafungin and caspofungin against Candida glabrata were evaluated. MICs, 50% inhibitory concentrations (IC50 values), and IC90 values for anidulafungin were lower than those for caspofungin for 16 of 18 strains tested. Anidulafungin has potent in vitro activity against C. glabrata that is maintained against isolates with elevated caspofungin MICs.
引用
收藏
页码:3926 / 3928
页数:3
相关论文
共 50 条
  • [41] Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes
    Posteraro, Brunella
    Sanguinetti, Maurizio
    Fiori, Barbara
    La Sorda, Marilena
    Spanu, Teresa
    Sanglard, Dominique
    Fadda, Giovanni
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 458 - 461
  • [42] Caspofungin activity against clinical isolates of fluconazole-resistant Candida
    Pfaller, MA
    Messer, SA
    Boyken, L
    Rice, C
    Tendolkar, S
    Hollis, RJ
    Diekema, DJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) : 5729 - 5731
  • [43] Evaluation of Caspofungin Susceptibility by Microdilution Broth in Candida albicans Clinical Isolates in Iran
    Fozouni, Leila
    Mohammadi, Shahla Roudbar
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2014, 8 : 147 - 152
  • [44] Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient
    Krogh-Madsen, M
    Arendrup, MC
    Heslet, L
    Knudsen, JD
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) : 938 - 944
  • [45] In vitro activity of three echinocandins (caspofungin, micafungin and anidulafungin) against Aspergillus spp.
    Martos, A. I.
    De la Escalera, C. Martin
    Lopez-Oviedo, E.
    Aller, A. I.
    Romero, A.
    Serrano, C.
    Valverde, A.
    Martin-Mazuelos, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S476 - S476
  • [46] Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin
    Garcia-Agudo, Lidia
    Garcia-Martos, Pedro
    Martos-Canadas, Jorge
    Aznar-Marin, Pilar
    Marin-Casanova, Pilar
    Rodriguez-Iglesias, Manuel
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2012, 25 (04) : 256 - 260
  • [47] Influence of culture media and inocula on the in vitro susceptibility of Candida species to caspofungin
    Fegeler, W
    Becker, K
    TRENDS IN MEDICAL MYCOLOGY, 2003, : 127 - 130
  • [48] Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging
    Persyn, Aranka
    Rogiers, Ona
    Brock, Matthias
    Vande Velde, Greetje
    Lamkanfi, Mohamed
    Jacobsen, Ilse D.
    Himmelreich, Uwe
    Lagrou, Katrien
    Van Dijck, Patrick
    Kucharikova, Sona
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [49] Susceptibility to caspofungin of Candida spp. strains isolated in Ceara, Northeastern Brazil
    Rocha da Silva, C.
    de Sousa Campos, R.
    Adalgiza dos Santos Neta, M.
    Rozelle Ferreira Angelo, M.
    Iury Ferreira Magalhaes, H.
    Coelho Cavalcanti, B.
    de Moraes, M. Odorico
    Silveira Macedo, D.
    Vitoriano Nobre Junior, H.
    JOURNAL DE MYCOLOGIE MEDICALE, 2011, 21 (04): : 273 - 276
  • [50] In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection
    de la Tabla-Ducasse, VO
    Masiá-Canuto, M
    Martín-González, C
    Gutiérrez-Rodero, F
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (06): : 328 - 331